Patient Association: International Neuroendocrine Cancer Alliance (European Union): Difference between revisions
From Beacon
No edit summary |
m (Update categories.) |
||
| Line 34: | Line 34: | ||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | ||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | ||
<span style="display:none">isPatientAssociation</span> | |||
Revision as of 16:57, 3 December 2025
Go back to European Union page
Primary purpose: To advocate globally for patients with neuroendocrine cancer and genetic neuroendocrine tumours (NETs) by raising awareness, promoting scientific advancements, and fostering collaboration to ensure timely diagnosis, optimal treatment, support, and care.
Cancer areas of interest: C15-C26: Digestive system cancers, C30-C39: Lung/chest cancers and C73-C75: Thyroid and other gland cancers.
Access to information: Click here to access.